Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 18-Jun-24 5:05 PM View:  | Api Group Corp (APG) | 17-Jun-24 | Private Sale | 1,951,780 | $38.15 | $74,460,496.00 | (7%) 28.98M to 27.03M | |
| 18-Jun-24 5:04 PM View: | Api Group Corp (APG) | 17-Jun-24 | Private Sale Duplicate | 1,951,780 | $38.15 | $74,460,496.00 | (7%) 28.98M to 27.03M | |
| 03-Jun-24 5:55 PM View: | Inhibrx, Inc. (INBX) | 30-May-24 | Disposition (other) | 7,150,830 | $30.00 | $214,524,992.00 | (100%) 7.15M to 0 | |
| 07-Mar-24 4:43 PM View: | Api Group Corp (APG) | 05-Mar-24 | Private Sale | 3,038,620 | $34.25 | $104,073,000.00 | (9%) 32.02M to 28.98M | |
| 07-Mar-24 4:44 PM View: | Api Group Corp (APG) | 05-Mar-24 | Private Sale Duplicate | 3,038,620 | $34.25 | $104,073,000.00 | (9%) 32.02M to 28.98M | |
| 01-Mar-24 4:17 PM View: | Api Group Corp (APG) | 28-Feb-24 | Conversion | 8,200,880 | $24.60 | $201,742,000.00 | 29% 27.89M to 36.09M | < 1% |
| 01-Mar-24 4:18 PM View: | Api Group Corp (APG) | 28-Feb-24 | Conversion Duplicate | 8,200,880 | $24.60 | $201,742,000.00 | 29% 27.89M to 36.09M | < 1% |
| 01-Mar-24 4:17 PM View: | Api Group Corp (APG) | 28-Feb-24 | Disposition (other) | 4,065,040 | $36.90 | $150,000,000.00 | (11%) 36.09M to 32.02M | |
| 01-Mar-24 4:18 PM View: | Api Group Corp (APG) | 28-Feb-24 | Disposition (other) Duplicate | 4,065,040 | $36.90 | $150,000,000.00 | (11%) 36.09M to 32.02M | |
| 28-Feb-24 4:30 PM View: | Rayzebio, Inc. (RYZB) | 26-Feb-24 | Disposition (other) | 6,642,700 | -- | -- | (100%) 6.64M to 0 | |
| 28-Feb-24 10:00 PM View: | Rayzebio, Inc. (RYZB) | 26-Feb-24 | Disposition (other) Duplicate | 6,642,700 | -- | -- | (100%) 6.64M to 0 | |
| 05-Jan-24 5:44 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 04-Jan-24 | Market Sale | 540,000 | $19.53 | $10,546,200.00 | (11%) 4.79M to 4.25M | 7% |
| 04-Jan-24 4:11 PM View: | Api Group Corp (APG) | 02-Jan-24 | Private Sale | 6,500,000 | $31.30 | $203,450,000.00 | (19%) 34.39M to 27.89M | |
| 04-Jan-24 4:15 PM View: | Api Group Corp (APG) | 02-Jan-24 | Private Sale Duplicate | 6,500,000 | $31.30 | $203,450,000.00 | (19%) 34.39M to 27.89M | |
| 21-Sep-23 4:59 PM View: | Rayzebio, Inc. (RYZB) | 19-Sep-23 | Conversion | 5,253,810 | -- | -- | 100% 0 to 5.25M | |
| 21-Sep-23 5:00 PM View: | Rayzebio, Inc. (RYZB) | 19-Sep-23 | Conversion Duplicate | 5,253,810 | -- | -- | 100% 0 to 5.25M | |
| 21-Sep-23 4:59 PM View: | Rayzebio, Inc. (RYZB) | 19-Sep-23 | Purchase | 1,388,890 | $18.00 | $25,000,000.00 | 26% 5.25M to 6.64M | |
| 21-Sep-23 5:00 PM View: | Rayzebio, Inc. (RYZB) | 19-Sep-23 | Purchase Duplicate | 1,388,890 | $18.00 | $25,000,000.00 | 26% 5.25M to 6.64M | |
| 30-Aug-23 8:44 PM View: | Inhibrx, Inc. (INBX) | 28-Aug-23 | Private Purchase | 511,627 | $19.35 | $9,899,980.00 | 8% 6.64M to 7.15M | |
| 19-Jul-23 9:33 PM View: | Bridgebio Pharma, Inc. (BBIO) | 18-Jul-23 | Private Sale | 1,500,000 | $35.00 | $52,500,000.00 | (6%) 26.62M to 25.12M | |
| 26-Jun-23 5:11 PM View: | Roivant Sciences Ltd. (ROIV) | 22-Jun-23 | Private Sale Duplicate | 13,000,000 | $9.90 | $128,700,000.00 | (15%) 88.24M to 75.24M | |
| 11-May-23 5:50 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 09-May-23 | Private Purchase | 850,000 | $16.00 | $13,600,000.00 | 22% 3.94M to 4.79M | |
| 25-Nov-22 1:35 PM View: | Frazier Lifesciences Acquis... (FLAC) | 22-Nov-22 | Conversion | 3,671,460 | -- | -- | (100%) 3.67M to 0 | |
| 04-Nov-22 6:17 PM View: | Frazier Lifesciences Acquis... (FLAC) | 02-Nov-22 | Purchase | 847,062 | $10.08 | $8,538,380.00 | 30% 2.82M to 3.67M | |
| 12-Oct-22 4:39 PM View: | Inhibrx, Inc. (INBX) | 07-Oct-22 | Private Purchase | 1,333,330 | $30.00 | $39,999,900.00 | 25% 5.31M to 6.64M | |
| 09-Sep-22 9:48 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 09-Sep-22 | Sale | 700,000 | $30.23 | $21,159,800.00 | (11%) 6.47M to 5.77M | |
| 09-Sep-22 9:48 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 08-Sep-22 | Private Sale | 700,000 | $29.37 | $20,559,900.00 | (10%) 7.17M to 6.47M | |
| 22-Mar-22 8:51 PM View: | Procept Biorobotics Corp (PRCT) | 18-Mar-22 | Private Sale | 1,249,000 | $29.90 | $37,345,100.00 | (25%) 4.91M to 3.66M | |
| 04-Mar-22 7:49 PM View: | Ginkgo Bioworks Holdings, I... (DNA) | 02-Mar-22 | Disposition (other) | 288,000,000 | -- | -- | (85%) 339.06M to 51.06M | |
| 13-Jan-22 9:05 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 11-Jan-22 | Conversion | 4,870,540 | -- | -- | 100% 0 to 4.87M | |
| 13-Jan-22 9:05 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 11-Jan-22 | Purchase | 2,300,000 | $19.00 | $43,700,000.00 | 47% 4.87M to 7.17M | |
| 21-Sep-21 10:00 PM View: | Procept Biorobotics Corp (PRCT) | 17-Sep-21 | Conversion | 4,199,750 | -- | -- | 1363% 308.14K to 4.51M | |
| 21-Sep-21 10:00 PM View: | Procept Biorobotics Corp (PRCT) | 17-Sep-21 | Market Purchase | 400,000 | $35.00 | $14,000,000.00 | 9% 4.51M to 4.91M | |
| 03-Sep-21 7:28 PM View: | Figs, Inc. (FIGS) | 03-Sep-21 | Market Sale | 42,413 | $44.92 | $1,905,190.00 | (< 1%) 14.79M to 14.74M | (< 1%) |
| 03-Sep-21 7:28 PM View: | Figs, Inc. (FIGS) | 02-Sep-21 | Market Sale | 157,587 | $47.28 | $7,450,710.00 | (1%) 14.94M to 14.79M | 4% |
| 02-Aug-21 8:40 PM View: | Rallybio Corp (RLYB) | 29-Jul-21 | Conversion | 3,388,780 | -- | -- | 100% 0 to 3.39M | |
| 02-Aug-21 8:40 PM View: | Rallybio Corp (RLYB) | 29-Jul-21 | Purchase | 806,000 | $13.00 | $10,478,000.00 | 24% 3.39M to 4.19M | |
| 17-Dec-20 9:15 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 15-Dec-20 | Conversion | 2,837,910 | -- | -- | 142% 2.0M to 4.84M | |
| 17-Dec-20 9:15 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 15-Dec-20 | Purchase | 1,100,000 | $23.00 | $25,300,000.00 | 23% 4.84M to 5.94M | |
| 16-Dec-20 9:03 PM View: | Adaptive Biotechnologies Corp (ADPT) | 14-Dec-20 | Sale | 1,000,000 | $55.65 | $55,650,000.00 | (3%) 30.99M to 29.99M | |
| 03-Dec-20 6:30 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 01-Dec-20 | Sale | 500,000 | $50.50 | $25,250,000.00 | (11%) 4.44M to 3.94M | |
| 13-Nov-20 9:01 PM View: | Adaptive Biotechnologies Corp (ADPT) | 11-Nov-20 | Sale Duplicate | 2,500,000 | $49.51 | $123,787,000.00 | (7%) 33.49M to 30.99M | |
| 28-Aug-20 4:29 PM View: | Inhibrx, Inc. (INBX) | 26-Aug-20 | Purchase | 180,219 | $18.92 | $3,409,870.00 | 4% 5.13M to 5.31M | |
| 25-Aug-20 7:47 PM View: | Inhibrx, Inc. (INBX) | 25-Aug-20 | Purchase | 85,304 | $19.36 | $1,651,690.00 | 2% 5.04M to 5.13M | |
| 25-Aug-20 7:47 PM View: | Inhibrx, Inc. (INBX) | 24-Aug-20 | Purchase | 46,161 | $19.43 | $897,000.00 | < 1% 4.99M to 5.04M | |
| 08-Apr-20 8:33 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 07-Apr-20 | Purchase | 725,000 | $18.00 | $13,050,000.00 | 19% 3.72M to 4.44M | |
| 30-Jan-20 4:52 PM View: | Adaptive Biotechnologies Corp (ADPT) | 28-Jan-20 | Sale | 4,912,900 | $24.98 | $122,706,000.00 | (13%) 38.41M to 33.49M | |
| 02-Jul-19 5:11 PM View: | Adaptive Biotechnologies Corp (ADPT) | 01-Jul-19 | Conversion | 36,731,600 | -- | -- | 2578% 1.43M to 38.16M | |
| 02-Jul-19 5:11 PM View: | Adaptive Biotechnologies Corp (ADPT) | 01-Jul-19 | Purchase | 250,000 | $20.00 | $5,000,000.00 | < 1% 38.16M to 38.41M | |
| 28-Jun-19 7:02 PM View: | Bridgebio Pharma, Inc. (BBIO) | 27-Jun-19 | Conversion | 21,915,100 | -- | -- | 100% 0 to 21.92M |